California lawmakers set aside $100 million in the recently adopted 2022-23 state budget to help launch the CalRx drug label, and the state could start producing generic insulin within the next few years.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
